Arcutis Biotherapeutics, Inc. (ARQT)

Last Three Months

19-Feb-24 -- 18-May-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Sentiment Breakdown by Insider

0

(3)

0

(2)

0

(1)

23

0

1

+1

0

+2

0

+3

Two Year Chart

19-May-22 -- 18-May-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
03-May-24 4:22 PM View:	02-May-24 Sale (Planned) ($83.49K)	Burnett Patrick See Remarks		Arcutis Biotherapeutics, Inc. - ARQT	(5%) 274.08K to 259.75K	0	0	--	--	Show Txns Hide Txns

03-May-24 4:22 PM View:	02-May-24 Sale (Planned) ($120.43K)	Watanabe Todd Franklin See Remarks Director		Arcutis Biotherapeutics, Inc. - ARQT	(3%) 1.12M to 1.09M	0	0	--	--	Show Txns Hide Txns

03-May-24 4:22 PM View:	02-May-24 Sale (Planned) ($43.83K)	Matsuda Masaru See Remark		Arcutis Biotherapeutics, Inc. - ARQT	(5%) 194.18K to 185.41K	0	0	--	--	Show Txns Hide Txns

03-May-24 4:29 PM View:	02-May-24 Sale ($40.90K)	Moore Matthew Richard SVP and Chief Business Officer		Arcutis Biotherapeutics, Inc. - ARQT	(3%) 149.49K to 145.5K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 4:28 PM View:	04-Mar-24 Private Purchase $199.99K	Heron Patrick J Director		Arcutis Biotherapeutics, Inc. - ARQT	0% 8.8M to 8.82M	0	0	--	--	Show Txns Hide Txns

11-Apr-24 8:32 PM View:	10-Apr-24 Grant 0	Topper David Joseph Chief Financial Officer		Arcutis Biotherapeutics, Inc. - ARQT	100% 0 to 110.0K	0	0	--	--	Show Txns Hide Txns